# Atea Pharmaceuticals, Inc.: Form SCHEDULE 13D, filed Dec 16, 2024

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: SCHEDULE 13D
- Filed: 2024-12-16
- Accepted by EDGAR: Dec 16, 2024, 14:50 ET
- Period: not reported
- Accession: 0001373604-24-000114
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000137360424000114/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000137360424000114/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000137360424000114/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001373604-24-000114. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.